Vysis UroVysion

Device Abbott Laboratories
Total Payments
$193,787
Transactions
47
Doctors
35
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2020 $500.00 1 0
2019 $2,371 23 21
2018 $6,244 7 3
2017 $184,672 16 11

Payments by Nature

Nature of Payment Amount Transactions Share
Royalty or License $150,000 1 77.4%
Consulting Fee $19,000 1 9.8%
Unspecified $9,891 8 5.1%
Travel and Lodging $9,289 1 4.8%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $4,500 1 2.3%
Food and Beverage $1,107 35 0.6%

Payments by Type

General
$183,896
39 transactions
Research
$9,891
8 transactions

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
Evaluation of the UroVysion Test in Predicting Recurrence and/or Progression of Disease in Patients Receiving initial BCG for Primary High Grade Ta-T1 and CIS Urothelial Carcinoma of the Bladder Abbott Laboratories $8,656 0
Evaluation of the UroVysion Test in Predicting Recurrence and or Progression of Disease in Patients Receiving initial BCG for Primary High Grade Ta-T1 and CIS Urothelial Carcinoma of the Bladder Abbott Laboratories $1,235 0

Top Doctors Receiving Payments for Vysis UroVysion

Doctor Specialty Location Total Records
Unknown Houston, TX $159,891 9
, MD Urology Iowa City, IA $19,000 1
, M.D Urology Minneapolis, MN $9,289 1
, M.D Urology Houston, TX $4,942 3
, PH.D Clinical Cytogenetics Phoenix, AZ $48.56 2
, MD Anatomic Pathology & Clinical Pathology Austin, TX $24.75 1
, MD Anatomic Pathology & Clinical Pathology Austin, TX $24.74 1
, MD Pediatrics Abilene, TX $24.74 1
, M.D Student in an Organized Health Care Education/Training Program Denver, CO $23.26 1
, MD Cytopathology Denver, CO $23.26 1
, M.D Urology Rochester, MN $22.88 1
, MD Urology Rochester, NY $22.88 1
, M.D Urology Los Angeles, CA $22.88 1
, M.D Urology Durham, NC $22.88 1
, MD Urology New Orleans, LA $22.87 1
, MD Urology Dallas, TX $22.87 1
, MD Anatomic Pathology San Antonio, TX $19.35 1
, MD Anatomic Pathology & Clinical Pathology San Antonio, TX $19.35 1
, MD Urology Bellevue, WA $18.86 1
, M.D Urology Bellevue, WA $18.85 1
, M.D Urology Bellevue, WA $18.85 1
, MD Urology Bellevue, WA $18.85 1
, MD Urology La Grange, IL $18.73 1
, MD Anatomic Pathology & Clinical Pathology Virginia Beach, VA $17.95 1
, M.D Urology Virginia Beach, VA $17.95 1

About Vysis UroVysion

Vysis UroVysion is a device associated with $193,787 in payments to 35 healthcare providers, recorded across 47 transactions in the CMS Open Payments database. The primary manufacturer is Abbott Laboratories.

Payment data is available from 2017 to 2020. In 2020, $500.00 was paid across 1 transactions to 0 doctors.

The most common payment nature for Vysis UroVysion is "Royalty or License" ($150,000, 77.4% of total).

Vysis UroVysion is associated with 2 research studies, including "Evaluation of the UroVysion Test in Predicting Recurrence and/or Progression of Disease in Patients Receiving initial BCG for Primary High Grade Ta-T1 and CIS Urothelial Carcinoma of the Bladder" ($8,656).